1. Home
  2. OBT vs ASMB Comparison

OBT vs ASMB Comparison

Compare OBT & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Orange County Bancorp Inc.

OBT

Orange County Bancorp Inc.

HOLD

Current Price

$30.88

Market Cap

410.5M

Sector

Finance

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$28.08

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OBT
ASMB
Founded
1892
2005
Country
United States
United States
Employees
225
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
410.5M
440.0M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
OBT
ASMB
Price
$30.88
$28.08
Analyst Decision
Buy
Strong Buy
Analyst Count
1
6
Target Price
$36.00
$43.40
AVG Volume (30 Days)
48.8K
94.1K
Earning Date
05-05-2026
01-01-0001
Dividend Yield
2.34%
N/A
EPS Growth
N/A
50.00
EPS
2.39
N/A
Revenue
N/A
N/A
Revenue This Year
$14.27
$33.33
Revenue Next Year
$7.99
N/A
P/E Ratio
$12.85
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.97
$7.76
52 Week High
$37.99
$39.71

Technical Indicators

Market Signals
Indicator
OBT
ASMB
Relative Strength Index (RSI) 34.17 46.78
Support Level $29.33 $26.50
Resistance Level $31.49 $30.66
Average True Range (ATR) 1.12 1.42
MACD -0.45 -0.03
Stochastic Oscillator 24.76 27.35

Price Performance

Historical Comparison
OBT
ASMB

About OBT Orange County Bancorp Inc.

Orange County Bancorp Inc provides banking services. Its services include personal banking services such as personal loans, personal savings, business loans, business savings, and Internet banking among others. The company provides commercial and consumer banking services to individuals, small businesses, and local municipal governments as well as trust and investment services through the Bank and HVIA. Its segment includes banking and wealth management. The company generates maximum revenue from the banking segment.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: